Drugs / VEGFR1
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 16 trials | ||||||
| Phase 1 | NCT00874588 | Mar 2009 → Jun 2012 | non-small cell lung carcinoma | Fukushima Medical University | Completed | No outcome recorded |
| Phase 1 | NCT00791570 | Oct 2008 → Apr 2012 | wet macular degeneration | Osaka University | Completed | No outcome recorded |
| Phase 1 | NCT01266720 | Apr 2008 → Mar 2010 | malignant pancreatic neoplasm | Fukushima Medical University | Unknown | No outcome recorded |
| Phase 1 | NCT00632333 | Feb 2008 → Dec 2011 | esophageal cancer | Teikyo University | Unknown | No outcome recorded |
| Phase 1 | NCT00561275 | Oct 2007 → May 2008 | esophageal cancer | Japanese Foundation for Cancer Research | Completed | No outcome recorded |
| Phase 1 | NCT00633724 | May 2007 → Jun 2012 | non-small cell lung carcinoma | Fukushima Medical University | Completed | No outcome recorded |
| Phase 1/25 trials | ||||||
| Phase 1/2 | NCT00677287 | May 2008 → Mar 2009 | colon carcinoma, rectal cancer | Tokyo University | Terminated | No outcome recorded |
| Phase 1/2 | NCT00681577 | May 2008 → Oct 2009 | gastric cancer | Tokyo University | Completed | No outcome recorded |
| Phase 1/2 | NCT00681421 | May 2008 → Apr 2009 | esophageal cancer | Tokyo University | Completed | No outcome recorded |
| Phase 1/2 | NCT00673777 | May 2008 → Apr 2009 | non-small cell lung carcinoma | Tokyo University | Unknown | No outcome recorded |
| Phase 1/2 | NCT00681252 | May 2008 → Apr 2009 | gastric cancer | Tokyo University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEGFR1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00791570 ↗ |
| Known as | VEGFR1, VEGFR2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01266720 ↗ |
| Modality | Peptide | “VEGFR1 peptide(1mg)” NCT00673777 ↗ |
| Route | Subcutaneous | “the URLC10 peptide (1mg), VEGFR1 peptide (1mg) and VEGFR2 peptide (1mg) mixed with Montanide ISA 51 will be administered by subcutaneous injection” NCT00681252 ↗ |
| Target | VEGFR1 | “Vascular endothelial growth factor receptor 1 (VEGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) are essential targets for tumor angiogenesis.” NCT00632333 ↗ |